Shree Pacetronix

Shree Pacetronix Net Debt per Share

The Net Debt per Share of Shree Pacetronix (527005.BO) as of Oct 28, 2026 is 10.66 INR. In the previous year, Net Debt per Share was 9.42 INR — a change of 13.20% (higher).

Net Debt per Share

10.66INR

YoY

13.20%

Last updated:

Net Debt per Share of Shree Pacetronix is 2025 10.66 INR. Net Debt per Share of Shree Pacetronix was 2024 9.42 INR. It decreases by 13.20% higher compared to the previous year.

The Shree Pacetronix Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2016
6.03 INR
Jan 1, 2017
8.79 INR
Jan 1, 2020
9.21 INR
Jan 1, 2021
7.97 INR
Jan 1, 2022
4.32 INR
Jan 1, 2023
3.55 INR
Jan 1, 2024
9.42 INR
Jan 1, 2025
10.66 INR
The Shree Pacetronix Net Debt per Share history
YEARNet Debt per ShareYoY
10.66INR+13.20%
9.42INR+165.18%
3.55INR-17.79%
4.32INR-45.82%
7.97INR-13.46%
9.21INR+4.81%
8.79INR+45.76%
6.03INR-26.73%
8.23INR+35.32%
6.08INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shree Pacetronix Stock analysis

What does Shree Pacetronix do? Shree Pacetronix Ltd. generates revenue through the sale of implantable cardiac pacemakers and related medical devices. The company's product portfolio includes multi-programmable pacemakers such as Ventralite 940 +/ Tiranga, Pinnacle 8820, and Tiranga 302, as well as rate responsive pacemakers like Charak DDDR and Pinnacle-R SSIR + Model 297. Bivent pacemakers such as Trinity R and external pacemakers including Indus I SSB and Zeus-1 are also sold. Additional products consist of pacing system analyzers, physician corners, and pacing leads like temporary leads, Screw-in lead P12 Model 3844 VB/ 3744VB, IS1 Bipolar Lead 3851 VB, and Atrial J Bipolar Lead 3851 VB. The company serves the Life Saving Devices segment with a focus on India and the Rest of the World, targeting healthcare providers and medical institutions requiring cardiac pacemaker solutions. Shree Pacetronix Ltd. operates under the Life Saving Devices segment, offering specialized medical equipment for cardiac care. Its subsidiary Shree Coratomic Limited supports the company's operations. The primary buyers are healthcare facilities and medical institutions in India and international markets, purchasing pacemakers and associated devices for patient treatment. Products are distributed through medical supply channels to hospitals and clinics specializing in cardiology. The firm's revenue streams are derived from the direct sale of its branded medical devices. Key products include the Ventralite 940 +/ Tiranga, Pinnacle 8820, Tiranga 302, Charak DDDR, Pinnacle-R SSIR + Model 297, Trinity R, Indus I SSB, Zeus-1, Smart-E programmer, and various pacing leads. These products are sold to healthcare providers globally, with significant market presence in India and the Rest of the World. The company's business model centers on providing essential cardiac care equipment through its comprehensive product range. Shree Pacetronix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shree Pacetronix stock

Net Debt per Share of Shree Pacetronix is 10.66 INR in 2025.

Net Debt per Share of Shree Pacetronix changed from 9.42 INR to 10.66 INR, representing a 13.20% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share Shree Pacetronix since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Shree Pacetronix

All Key Metrics — Shree Pacetronix